Therapy Area/Business Area
Auto-Immune/Early Commercial Development
The Business Issue
- Should the R&D and Marketing teams make significant further investment in funding Phase II trials for this novel Quinolone drug indicated for anti-MRSA activity for HAP, VAP and SSTI?
The Impact
- Redefine the TPP and support the decision to move the drug through Phase II
The SmartAnalyst Approach
- Produce scope in collaboration with client
- Market Opportunity Assessment including primary market research findings
- A revenue forecast model which was presented to senior management
The Output (4 week turnaround)
- Collection and analysis of a wide and complex range of secondary data
- Primary market research and expert analysis that would reduce the massive amount of information to a go/no-go recommendation
|
|
 |
Pharmaceutical Case Studies:
Business Development
Corporate Development
Commercial Development
New Product Planning
Marketing
Risk Management
Strategic Development
Licensing & Acquisition
Forecasting
Research & Development
Competitive Intelligence
Brand Management
Clinical Development & Regulatory
Information Sciences
Pre-Launch Planning
Post-Launch Planning |
| |
|
|